The prostate causes problems for many men as they age, sometimes triggered by benign enlargement of the prostate gland (BPH = benign prostatic hyperplasia). Symptoms may include frequent need to urinate, urinary tract dysfunction or inflammation.
Prostatic artery embolization
Confraternität Private Hospital offers a new and minimally invasive form of treatment for complaints of benign enlargement of the prostate that cannot be alleviated by medication: prostate artery embolization (PAE).
The method was established and developed in close interdisciplinary cooperation by Prof. Markus Margreiter (urologist) and Prof. Florian Wolf (interventional radiologist) in Austria and since 2014 has been offered as a routine intervention.
Prostate artery embolization (PAE) is minimally invasive, can be performed without general anesthetic, and offers a gentle alternative to surgery. Under local anesthetic, a slim catheter is inserted via a femoral artery into the prostate artery. Using tiny synthetic pellets, the small branches of this artery are sealed off. This blocks the supply of oxygen and nutrients, causing the prostate to contract.
Patients usually experience a marked improvement shortly after this procedure; associated side effects occur only in rare cases. For some patients PAE makes long-term medication unnecessary.
Rezum Water Vapor Therapy
Confraternität Private Hospital is the first private hospital in Austria to offer Rezum Water Vapor Therapy, a new, minimally invasive method to treat an enlarged prostate.
This minimally invasive, endoscopic method uses steam to eliminate excess prostate tissue. Following the intervention, the prostate will continue to shrink — for up to several weeks after, depending on the size. The procedure is much gentler on the patient than an operation and produces no unwelcome side effects.
Priv.-Doz. Dr. Markus Margreiter about Rezum Water Vapour Therapy of prostate gland
iTind - the third and latest treatment option for benign prostate enlargement and bladder neck obstruction - is a small basket that is implanted temporarily. The procedure takes only a few minutes and is usually performed under light sedation. iTind is a type of stent that uses gentle pressure to stretch the bladder outlet, thus allowing for more space and improving urine flow rate. The basket remains in the prostate area for only five to seven days and is then removed again.
Pioneer in Austria: iTind was successfully applied for the first time in Austria by Priv.-Doz. Dr. Markus Margreiter and his team at the Confraternität Private Hospital in 2021 and has established itself as a further minimally invasive and therefore gentle treatment method in addition to the PAE and Rezum Water Vapour treatment.
Priv.-Doz. Dr. Markus Margreiter about iTind, a minimally invasive treatment for benign prostatic hyperplasia